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Rare pathological mutations in a small group of genes in humans
can lead to pain insensitivity,4,19 and such cases have been
instrumental in driving drug discovery programs for new analge-
sics.75 A less frequently trodden track is the examination of why
some animals have evolved specific types of pain insensitivity. In
this review, I will focus on insights that the biology of African mole-
rats has given us in understanding the molecular basis of naturally
occurring pain insensitivity.27,89,91,114 Many millions of years ago,
evolution selected for changes inAfricanmole-rat genes producing
specific types of pain insensitivity.27 It is striking that evolution
selected for changes in genes and signal transduction pathways
that were subsequently identified as being critical for human
nociception, which is a major theme of this short review.
It has long been known that naturally occurring chemical
substances, called algogens, evoke painful sensations or avoidance
in animals and humans. One of the best characterized algogens is
capsaicin, a natural substance and the active ingredient of chili
peppers, and the substance that confers theburnof hot peppers.11,12
There is a huge literature on capsaicin, characterizing its neurotoxic
effects in neonatal animals, as well as its use as a substance to
produce acute experimental pain in humans.41,124 Capsaicin causes
burning sensations in humans and is thought to induce a similar
sensation in most vertebrates, one major exception being all birds,
which have evolved insensitivity to capsaicin likely because they are
seed carriers for capsicum plants.49 It is not clear when capsaicin
insensitivity evolved in the bird lineage, but it is possible that the
ancestors of birds, ie, nonavian dinosaurs, were already insensitive to
capsaicin. In 2008, we discovered that capsaicin was not a universal
irritant inmammals because our studies on the nociceptive system of
the nakedmole-rat (Heterocephalus glaber) revealed that this unusual
subterranean mammal was completely insensitive to capsaicin.91
Further experiments also revealed that the nakedmole-rat displays no
nerve growth factor (NGF)-induced thermal hyperalgesia,66,91 a phe-
nomenon that is dependent on the presence of the capsaicin-
activated ion channel TRPV1.17
Naked mole-rats have fascinated biologists for several decades
because this underground-dwelling species native to East Africa
has a unique biology. Naked mole-rats are 1 of only 2 eusocial
mammals that live in very large colonies (up to 300 individuals) with
a single breeding female who is the queen.42,43 In the late 1970s,
Dr Jenny Jarvis from the University of Cape Town was the first to
show that these animals could be kept and bred in the laboratory,
and today naked mole-rat colonies are maintained in many
laboratories worldwide. Naked mole-rats have so many extreme
physiological features that wewould need an entire review to detail
them all. Some of their most striking physiological adaptations
include an extraordinarily long maximum life span of at least 36
years,100 apparent resistance to cancer, and resistance to extreme
hypercapnia and hypoxia.92 In this review, I will examine the
questions of how and why naked mole-rats, and more recently
other African mole-rat species, lost certain types of pain sensitivity.
2. Nerve growth factor: recent history
The naked mole-rat evolved changes in the NGF signaling that
probably underlies pain insensitivity in this species.89,91 Nerve
growth factor is the founding member of the neurotrophin family. In
the past 20 years, the link between the biology of NGF and pain has
been well established.35,60,73,95 There are at least 5 major
pharmaceutical companies running clinical trials of humanized
antibodies designed to sequester NGF for the treatment of pain in
conditions as varied as osteoarthritis, lower backpain, and interstitial
cystitis.8,14,28,52,57,106 The first example of an NGF-sequestering
drug is tanezumab, a humanizedmonoclonal antibody that potently
binds NGF developed by Rinat/Pfizer.57 At the time of writing, it was
not clear whether such drugs will gain regulatory approval because
a very small percentage of treated patients had experienced severe
joint damage as a side effect of treatment.106 Because an NGF
signaling axis is undoubtedly important in the etiology of pain, it is
important to understand how NGF functions in the context of
nociception and above all in the context of inflammatory hyper-
algesia. Here, I will briefly review the mechanistic basis of how NGF
functions in nociception and chronic pain.
The availability of antibody tools to manipulate the endogenous
levels of NGF allowed researchers to address the functional
consequences of NGF sequestration. Initially, efforts focused on
identifying precisely which neuronal populations depend on NGF
for survival and when. It is through such experiments and later
genetics that we got to know that NGF is required for the survival of
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sympathetic ganglion neurons and a large proportion of embry-
onic sensory neurons that are destined to become nocicep-
tors.23,101,102 It seems that both sympathetic and sensory neurons
largely lose their absolute dependency on NGF for survival in the
postnatal period.101,102
In the 1980s and 1990s, developmental biologists asked which
neurons required the neurotrophins for survival during develop-
ment.59 For example, it was known that all sensory neurons that
express TrkA (tropomyosin receptor kinase A, also known as
NTRK1), the main receptor of NGF during embryonic development,
require NGF to survive, but it was also clear that this population is not
phenotypically homogenous.23,74 Nerve growth factor continues to
be synthesized in the peripheral targets into adulthood and it has long
been noted that the levels of NGF in the target correlate very well with
thedensity of sympathetic and sensory innervation.54,59,109 Studies in
the 1980s already showed that it is primarily neuropeptide-containing
nociceptive sensory neurons in the adults that respond to NGF.59
Thus the neuropeptide content, primarily substance P (SP) and
calcitonin gene-related peptide (CGRP), of sensory neurons in-
nervating tissues high in NGF, such as the skin, was observed to be
high compared to tissues low in NGF.78 Lindsay and Harmar had
already demonstrated that NGF directly upregulates the SP content
of adult sensory neurons.69 TrkA receptor expression is a feature of all
developing nociceptors in the embryo, but its expression is
extinguished in postnatal, small-diameter, nonpeptidergic nocicep-
tors.83 The high-affinity TrkA receptor, which is the primary NGF-
signaling receptor, is coexpressed in neuropeptide-positive nocicep-
tors in adults. Inmature animals, theperipheral tissue couldbe shown
to influence the chemical composition of sensory afferents. Thus, in
experimentswhere a cutaneousnervewas rerouted to theNGF-poor
skeletal muscle and a muscle nerve was rerouted to NGF-rich skin,
the SP content changed to match that characteristic of the new
target, eg, muscle nerve innervating skin now had a high SP
content.77,78 What was even more striking was the fact that the
central connectivity of muscle afferents that had been redirected to
skin now resembled that of normal skin afferents.62 These results led
us to conduct the first serious test of the idea that a neurotrophic
factor could regulate synaptic strength in the nervous system. We
decided to artificially raise the levels of NGF in the skeletal muscle, in
this case the gastrocnemius muscle, by chronically pumping NGF
into themuscle. Bymaking extracellular recordings fromspinal dorsal
horn neurons, we knew that only very few of these neurons receive
strong synaptic drive from afferents innervating skeletal muscle.
However, after exposure to NGF, skeletal muscle afferents showed
a huge increase in their ability to excite dorsal horn neurons and this
increase was very large when compared to effects of muscle
afferents innervating the contralateral, untreated muscle.68 This was
the very first demonstration that a neurotrophic factor can modulate
synaptic strength. Shortly afterwards, an elegant and perhaps more
direct proof of this idea came from the laboratory of Moo Ming Poo,
which showed that both neurotrophin-3 and brain-derived neuro-
trophic factor (BDNF) can increase the strength of neuromuscular
synapses in vitro, with a surprisingly fast time course in the range of
seconds.71 Together, these studies provided the foundation of
a huge and important area of study, namely how neurotrophins
regulate synapses and synaptic strength in the nervous system.
3. Nerve growth factor and hyperalgesia: the linchpin
theory 1993
Hyperalgesia is defined as an increase in the felt intensity of
a noxious stimulus, usually after an injury or an inflammatory
process. Secondary hyperalgesia is the area of hypersensitivity
surrounding an injured area that is not due to peripheral
sensitization of the primary afferent because the afferents that
innervate the secondary area cannot be directly sensitized by the
injury. This type of hyperalgesia is thought to be due to
sensitization of central circuits to afferent input coming from
nearby the initial injury site.65,80,124 During the 1980s, it was
becoming increasingly clear that the neurobiological basis of
secondary hyperalgesia was to a large extent dependent on
a phenomenon termed central sensitization.20,79,127 Thus, strong
activation of nociceptors leads to a rapid and long-lasting
plasticity at synapses between primary sensory neurons and
dorsal horn neurons, and this long-lasting change in synaptic
strength can sustain hyperalgesia. Hyperalgesia is induced after
injury or inflammation, but can also be produced after skin
application of substances that activate or sensitize nociceptors. A
classic example of algogen-induced heat and mechanical
hyperalgesia is that after application of capsaicin to the skin.56
While working on the role of NGF in determining the phenotypic
identity of nociceptors in Lorne Mendell’s laboratory,61,99 Amy
Ritter and myself noted that rats that had been exposed to daily
injections of NGF were behaviorally more sensitive to mechanical
and heat stimuli than untreated animals. These observations led
us to make a more systematic study of the effects of NGF on
nociceptive behaviors in the rat. To our surprise, a single systemic
injection of NGF (1 mg/kg body weight) produced profound heat
and mechanical hyperalgesia, which lasted for several days.
Interestingly, heat and mechanical hyperalgesia seemed to be
mechanistically distinct because heat hyperalgesia appeared
within minutes, whereas mechanical hyperalgesia first became
apparent around 7 hours after the injection, becoming maximal
and sustained at 24 hours.67 The fact that a single molecule,
NGF, can set into motion a series of rapid functional changes with
all the hallmarks of hyperalgesia normally seen after sterile
inflammation raised the obvious question of whether NGF was
necessary for inflammatory hyperalgesia. This question was
particularly pertinent in light of data published showing that NGF
was upregulated in the sciatic nerve after inflammation of the
skin.26 It then became obvious to use blocking antibodies in vivo
to show whether an inflammation-dependent rise in NGF was
a necessary first step in producing hyperalgesia. After obtaining
preliminary data using NGF-blocking antibodies, a new model of
inflammatory hyperalgesia was proposed where NGF represents
a linchpin molecule that provides the key humoral link between
inflammation and the nociceptive sensory neurons that initiate
and sustain heat and mechanical hyperalgesia.63 The key
features of this model are shown in Figure 1, highlighting the
areas of progress that have been made since the discovery that
NGF is necessary for inflammatory hyperalgesia. Soon after we
reported that NGF could induce hyperalgesia, we as well as other
groups tested whether NGF-blocking antibodies could amelio-
rate or block inflammation-associated heat and mechanical
hyperalgesia (Fig. 1A). The first 2 reports showed that both the
heat and mechanical hyperalgesia that follow a complete
Freund’s adjuvant (CFA)-induced inflammation could be amelio-
rated by the administration of NGF-blocking antibodies.67,128
Later on, trkA-IgG fusion proteins (extracellular domain of TrkA
fused to the human Fc portion of the immunoglobulin G) that
specifically bind endogenous NGF were also shown to be
capable of ameliorating heat and mechanical hyperalgesia
associated with a carrageenan-evoked inflammation model in
rats.76 The key finding that blockade of NGF-signaling in
inflammatory conditions has a major analgesic effect has now
been validated in many models.47,95 It is important to note that
recombinant human NGF has also been administered to humans
with almost identical effects to those seen in animals.60,94,103
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Weproposed amechanistic model illustrating the various ways
in which increased NGF could produce heat and mechanical
hyperalgesia after inflammation.63 One key feature of this model
was the idea that the mechanisms that underlie the NGF-
dependent heat hyperalgesia are distinct from those that underlie
the mechanical hyperalgesia.67,67 We supposed that an impor-
tant difference was that NGF is capable of inducing extremely
rapid changes in the peripheral terminals of C -fibers that sensitize
Figure 1.Mechanisms of peripheral and central sensitization. (A) Peripheral sensitization may result from post-translational modifications (top andmiddle panel) or
from increased gene expression and the insertion of additional mechanically gated ion channels in the plasmamembrane of the peripheral nerve terminal (bottom).
(B) Nerve growth factor (NGF) signaling induces the release of substance P, BDNF, and CGRP from the central terminals of sensory neurons, which sensitize
NMDA receptors in second-order projection neurons resulting in the strengthening of synaptic transmission in the spinal dorsal horn—ie, central sensitization.56
BDNF, brain-derived neurotrophic factor; CGRP, calcitonin gene-related peptide.
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them to noxious heat stimuli. Mechanical hyperalgesia, however,
seemed to require the induction of changes in geneexpression that
eventually leads to central sensitization that maintains mechanical
hyperalgesia.67,67 In the past 20 years, much progress has been
made in elucidating the molecular mechanisms that underlie
peripheral NGF-dependent heat hyperalgesia. Progress has also
been made in understanding NGF-dependent mechanical hyper-
algesia and new data indicate that both central and peripheral
mechanismsmay be important, themolecular basis of which is just
beginning to be unraveled, reviewed in 60. One mechanism that
seems to be important for the maintenance of central sensitization
is the NGF-induced increase in release of BDNF from the central
terminals of nociceptors (Fig. 1B).31,34,81 Release of BDNF from
the central terminals of TrkA-positive nociceptors activates the
BDNF receptor TrkB on spinal interneurons and this is thought to
lead to postsynaptic plasticity through phosphorylation of the
NMDA receptor (N-methyl-D-aspartate). For a more detailed
review on the mechanisms of NGF-induced central sensitization,
see Refs. 60, 95.
4. The nociceptive system in naked mole-rats
The first detailed examination of sensory anatomy in the naked
mole-rat demonstrated that the skin of this largely hairless
species is innervated by both myelinated and unmyelinated
fibers.90 In most rodents, unmyelinated fibers can be subdivided
into peptidergic and nonpeptidergic fibers based upon their
expression of neuropeptide neurotransmitters such as CGRP
and SP.85,110,118 However, in the naked mole-rat, unmyelinated
fibers in the skin were observed to be virtually devoid of SP and
CGRP immunostaining. The lack of neuropeptide-positive
sensory neurons in the naked mole-rat raised the question of
whether this species had lost this sensory population in the
course of evolution. One way to examine such a question is to
quantify the numbers of unmyelinated axons in peripheral nerves,
which is normally done with transmission electron microscopy.
Many groups have quantified the numbers of myelinated (A
-fibers) and unmyelinated (C-fibers) in cutaneous nerves and
consistently observed that there are always 3 to 4 times as many
C -fibers as A -fibers in these nerves.115 However, in nakedmole-
rats, this ratio is just;1.5:1 and the low ratio is due to an absolute
paucity of unmyelinated nociceptors and not due to increased
numbers of A-fiber axons.89,91,115 Thus, nakedmole-rats have far
fewer cutaneous nociceptors than other similarly sizedmammals,
which prompted us to study related subterranean mole-rat
species that are phylogenetic neighbors to the naked mole-rat. In
a comparative study of nerves from 6 species belonging to the
Bathyergidae, the naked mole-rat was the only species with
markedly low cutaneous C-fiber to A-fiber ratio.115 An analysis of
the A-fiber and C-fiber numbers related to surface area de-
termined that this was accounted for by a paucity of C-fibers,
rather than an overabundance of A-fibers.115 It is likely that
mammals have evolved high-density cutaneous nociceptor
innervation as the skin is constantly exposed to potentially
damaging stimuli. Consistent with this idea, nerves that innervate
muscle and joints do not display high ratios of C fibers to A fibers
as is seen in the skin and this is true of all mammals examined.
Indeed, all bathyergids, including the naked mole-rat, and a wide
range of mammals typically display a;1:1 C-fiber to A-fiber ratio
in muscle nerves.44–46,115 A parsimonious explanation for the
cutaneous C-fiber deficit in naked mole-rats is that they largely
lack fur, although specialized sensory hairs are present.22
Compared to most other mammals, humans are relatively naked
and lack dense body hair; however, human cutaneous nerves
also show a;4:1 C-fiber to A-fiber ratio.87 In normal mice, it has
been observed that there is ongoing naturally occurring cell death
of sensory neurons with C-fiber axons in the early postnatal
period. This loss of axons is reflected in a drop in the C-fiber to A-
fiber ratio from ;6:1 in neonates to ;4:1 in adults. We recently
observed a similar, but more extreme, process in naked mole-
rats, such that postnatal day 3 naked mole-rat pups have a C-
fiber to A-fiber ratio of ;6:1 that drops to ;1:1 in adults.89 The
factors that might cause nociceptor loss are discussed below in
relation to the biology of NGF and its receptor TrkA.
5. Nociceptor function and nocifensive behaviors
in mole-rats
Transgenic mice that lack CGRP and SP show diminished pain
behaviors10,105 and thus the absence of neuropeptides in naked
mole-rat nociceptors initially raised the question ofwhether naked
mole-rats display pain insensitivity due to reduced nociceptor
function. The existence of nociceptors is almost completely
ubiquitous in the animal kingdom and even the nematode worm
Caenorhabditis elegans, with approximately 300 neurons, has
a dedicated set of nociceptors.113,120 Indeed, the fundamental
importance of nociceptors is demonstrated by humans with
congenital insensitivity to pain (CIP), a syndrome that can arise
due to a complete absence of nociceptive Ad-fibers and C
-fibers.97,119 The loss of nociceptors observed in some individ-
uals with CIP is chiefly due to mutations in NGF or its receptor
TrkA.40 Consistently, mice in which the gene encoding the NGF
receptor TrkA was ablated also lack C-fibers.111 Congenital
insensitivity to pain and nociceptor loss is also associated with
mutations in other genes, for example, PRDM12 (PRDI-BF1 and
RIZ homology domain-containing protein 12).16 Interestingly, this
transcriptional regulator seems to be necessary for normal
developmental expression of the NGF receptor TrkA.25,86
Despite the fact that cutaneous nerves in nakedmole-rats have
a depleted number of C-fiber nociceptors, our physiological
studies have shown that the receptor properties of these neurons
do not differ significantly from C-fibers in mice.91 This was the
case for saphenous nerve Ad -fibers with nociceptive properties,
as well as for C-fiber nociceptors as measured using an ex vivo
skin nerve preparation.82,84,126 The major C-fiber nociceptor
population is classified as polymodal receptors (ie, responding
both to mechanical and thermal stimuli) and they make up the
majority of C -fibers (60%-70%).30,53,64,65 The second population
are C-fibers, which are activated only by intense mechanical
stimuli and which make up the remaining functional population
seem to have different mechanosensitive properties compared to
polymodal C fibers.6,82 Interestingly, these 2 C-fiber populations
were present in naked mole-rats with receptor properties that
were almost identical to those of other rodents.91 Thus, the loss of
C-fibers in the naked mole-rat does not seem to be due to loss of
one functional subpopulation and the lack of neuropeptides in
these C fibers seems to be unrelated to their receptive properties.
The differences in nocifensive behaviors between other
rodents and the naked mole-rat were more dramatic when we
examined their behavioral response to algogens. Algogens are
chemicals that directly produce pain sensation in humans and
animals and often work by directly activating specific ion channels
or receptors expressed by nociceptors, thereby potently activat-
ing sensory receptors that initiate pain. Capsaicin is a prototypical
algogen andwhen injected intomice, evokes a nocifensive licking
response, which is due to its specific activation of the transient
receptor potential vanilloid 1 channel (TRPV1), a heat-, capsaicin-
, and acid-gated ion channel expressed by nociceptors.12,13,124
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Capsaicin robustly activates naked mole-rat polymodal C fibers
as determined by direct electrophysiological recordings with the
ex vivo skin-nerve preparation and patch clamp recordings from
isolated dorsal root ganglia (DRG) neurons.89,91,114 However,
despite the fact that naked mole-rat nociceptors are activated by
capsaicin, it fails to evoke any licking behavior in naked mole-
rats.27,91 In addition, whereas administration of capsaicin causes
sensitization of the response to heat (thermal hyperalgesia), this
phenomenon also does not occur in naked mole-rats.91 How
then is it that capsaicin activation of nociceptors does not lead to
pain behavior? Themajority of nociceptive input to the spinal cord
terminates in the superficial dorsal horn121,122 and because DRG
neurons are pseudounipolar, proteins that are expressed at the
peripheral terminal are also commonly expressed at the pre-
synaptic terminal in the dorsal horn. Consequently, one canmake
recordings from spinal cord neurons and apply capsaicin to
activate presynaptic terminals of TRPV1-expressing nociceptors,
which produces an excitatory postsynaptic current in the second-
order neurons with which TRPV1-positive nociceptors are
connected.129 In mice, the majority of postsynaptic neurons that
are synaptically driven by TRPV1-positive nociceptors are located
in the superficial dorsal horn, but in the naked mole-rat just as
many deep dorsal horn neurons are coupled to capsaicin-
sensitive nociceptors as are neurons in superficial layers.91 This
altered connectivity of TRPV1-positive nociceptors potentially
explains why capsaicin elicits a robust nocifensive response in
mice, but none in the naked mole-rat. Thus, activation of
capsaicin-sensitive nociceptors in the naked mole-rat simulta-
neously activates both superficial and deep dorsal horn neurons.
We speculate that reciprocal connections between synaptically
driven interneurons in the superficial and deep dorsal horn could
under such circumstances negate a pain signal. Interestingly,
when SP was introduced into the naked mole-rat, for example
through intrathecal injection, capsaicin injected into the paw was
newly able to evoke a nocifensive licking response and provoked
thermal hyperalgesia.91 The neurokinin-1 receptor (NK1R) for SP
is only present in the superficial dorsal horn of the naked mole-rat
spinal cord and thus presumably activation of nociceptors by
capsaicin in the presence of spinal SP leads to a stronger
activation of superficial layers that may allow gating of a noci-
fensive response.91 Administration of SP was also shown to
“rescue” histamine-induced itch in nakedmole-rats112 and evoke
a thermal hyperalgesia that is both NMDA receptor- and NK1R-
dependent.7
6. Inflammatory pain in mole-rats
In addition to changes in acute nociception, a variety of
inflammatory stimuli have been used to examine the development
of hyperalgesia in naked mole-rats. Formalin is a substance that
evokes acute and late phases of nocifensive behaviors, which
although occurring in the naked mole-rat are diminished
compared to mice.27,91 As discussed above, capsaicin fails to
evoke thermal hyperalgesia in the naked mole-rat and a similar
absence of thermal hyperalgesia was observed after administra-
tion of CFA and NGF, although mechanical hyperalgesia was
evoked by CFA.91 Nerve growth factor–induced thermal hyper-
algesia is a TRPV1-dependent process,17 but naked mole-rat
sensory neurons respond to capsaicin, which suggests that loss
of function in naked mole-rat TRPV1 is unlikely to explain the
absence of NGF-induced thermal hyperalgesia. Indeed, sub-
sequent analysis of naked mole-rat TRPV1 demonstrated that it
has normal heat, pH, voltage, and capsaicin sensitivity.114 Naked
mole-rat sensory neurons also express the NGF receptor TrkA,
but even in cultured DRG neurons, NGF fails to induce
sensitization of TRPV1.89,91 However, NGF sensitizes naked
mole-rat TRPV1 when expressed in sensory neurons from mice
that lack TRPV1 and when coexpressed with rat TrkA in naked
mole-rat fibroblasts, results ruling out deficits in naked mole-rat
TRPV1 and the nakedmole-rat cellular environment, respectively.
Indeed, experiments using naked mole-rat TrkA and a chimeric
TrkA (extracellular rat/intracellular nakedmole-rat) further showed
that activation of the naked mole-rat TrkA receptor is much less
efficient at producing NGF-induced TRPV1 sensitization, thus
indicating that the deficit lies in the intracellular domain.89
Furthermore, quantitative proteomics demonstrated that NGF
activation of chimeric TrkA receptors is less efficient in engaging
downstream signaling as shown by reduced abundance of
phosphopeptides compared to rat TrkA. Thus, the lack of NGF-
induced thermal hyperalgesia in naked mole-rats is almost
certainly primarily due to TrkA hypofunctionality.89 Examination
of the naked mole-rat TrkA sequence shows that between 1 and
3 amino acid substitutions that are unique to the naked mole-rat
in the kinase domain of TrkA are likely responsible for the
hypofunctional signaling observed.89 To confirm the role of
changes in the TrkA kinase domain underlying the phenotypes
observed in the naked mole-rat, one would ideally make
a transgenic naked mole-rat with the mouse TrkA sequence,
but this is currently not feasible. However, we have generated
mice with the critical residues from the naked mole-rat
reengineered into the mouse genome. Initial results with these
mice indeed indicate that they show reduced inflammatory pain
phenotypes (unpublished results). Thus, since the nakedmole-rat
ancestor appeared more than 30 million years ago, the mole-rat
had already blindly discovered the analgesic potential of reduced
NGF signaling. The molecular tools available to study laboratory
rodents such asmice are extremely powerful in themodern age of
deep sequencing and single-cell transcriptomics.32,125 However,
the same methods can also be applied to non-model organisms,
such as the naked mole-rat. We recently generated and
published a very large data set that enabled us to directly
compare the expression levels of nearly 7000 orthologous
transcripts from the DRG and spinal cord, not only between the
naked mole-rat and mouse, but also across 6 other related
African mole-rat species.27 We have made all these data freely
available so that sequence variants across 8 species as well as
expression levels of orthologous transcripts can be accessed and
analyzed online (https://moleratexpress.mdc-berlin.de). Here, I
used these publicly available data to examine the idea that the
PRDM12 gene, mutations in which can cause CIP in humans,
may show reduced expression or unique sequence variants in the
naked mole-rat (Fig. 2). It is clear that 2 CIP genes, Prdm12 and
TrkA, show reduced expression in the naked mole-rat DRG
compared to the mouse (Fig. 1A); in addition, the Trpv1 also
shows reduced expression (Fig. 1A). The PRDM12 gene has
been shown to be a key developmental regulator of nociceptor
differentiation and is important for the development of TrkA-
positive nociceptors.3,25,86 PRMD12 is a highly conserved
protein, which has a polyalanine stretch at the C-terminus, the
expansion of which has been directly implicated in pathogenic-
ity.16 Using public databases as well as transcriptomes assem-
bled from our own RNAseq data, we aligned the naked mole-rat
PRDM12 sequence against human, chimpanzee, mouse, and 2
African rodent species to look for amino acid variants that might
be unique (Fig. 2B). Initial analysis indicates that the naked mole-
rat sequence has a relatively expanded polyalanine sequence
compared to other mammals and possesses 2 seemingly unique
amino acid variants in the C-terminal region of the protein. There
S40 G.R. Lewin·161 (2020) S36–S47 PAIN®
Figure 2. (A) Comparison of mRNA levels for Prdm12, Ntrk1, and Trpv1 in the DRG of mouse and naked mole-rat, using RNAseq data sets downloaded from
https://moleratexpress.mdc-berlin.de. All statistics, unpaired t test; PRDM12, P 5 0.0213; NTRK1, P 5 0.0049; TRPV1, P 5 0.0003. (B) A multiple sequence
alignment of the predicted amino acid sequence of humanmouse and chimpanzee PRDM12 (downloaded fromUniprot) plus alignments with 3 predictedmole-rat
amino acid sequences, East African root-rat, and Mahali mole-rat (both sequences down loaded from https://moleratexpress.mdc-berlin.de) and derived from
a de novo transcriptome assembly.25 The naked mole-rat sequence was also downloaded from Uniprot. Note that the root-rat and Mahali sequences may be
truncated as an artifact of the de novo assembly. Asterisks (*) indicate positions where human missense mutations were originally identified. Ampersand (§)
indicates 2 positions where a unique amino acid variant seems to be present in the nakedmole-rat sequence. Green bar indicates the polyalanine sequence that is
as long in the mole-rat as it is in the human sequence.
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is thus a possibility that this protein may be involved in the
development of the unusual nociceptive system in the naked
mole-rat. The PRDM12 gene is still expressed in adult sensory
neurons (Fig. 2), but it is unknown if this protein has a role in
maintaining nociceptor physiology in the adult.
7. Absence of acid-induced pain in naked mole-rats
In addition to capsaicin-insensitivity, naked mole-rats also show
no pain behavior in response to foot pad injection of acid.91 Acidic
solutions (eg, pH 3.5, similar acidity to lemon juice) cause stinging
pain in humans.98,116 Nocifensive responses to acid solutions
have been observed throughout the animal kingdom,113 which
makes the lack of acid response observed in naked mole-rats
almost unique (see below). Moreover, although capsaicin
activates naked mole-rat C-fibers, no acid excitation of naked
mole-rat C-fibers was observed; in mice, all acid-activated C
fibers are normally also capsaicin sensitive.96
Acid, or more specifically protons, can activate sensory
neurons by the modulation or activation of several different
classes of ion channels including activation of TRPV1, acid-
sensing ion channels (ASICs), and proton-sensing G-protein-
coupled receptors and inhibition of certain 2-pore K1 chan-
nels.38,93 Direct electrophysiological studies have shown that
naked mole-rat DRG neurons display depolarizing currents to
proton application; indeed, both TRPV1-like and ASIC-like inward
currents have been observed107,114 and expression of different
ASIC subunits seems to be roughly equivalent between mouse
and naked mole-rat sensory neurons.108 When examining the
proton sensitivity of cloned acid-sensitive proteins, naked mole-
rat TRPV1, ASIC1a, and ASIC1b have a similar proton sensitivity
to their mouse orthologues114; however, the ASIC3 subunit is
proton insensitive and seems to shift the proton sensitivity when
present in heterotrimers, which may alter sensory neuron acid
sensitivity to some extent.107 It was thus puzzling that isolated
naked mole-rat sensory neurons can be excited by protons, but
we did not observe acid-driven action potentials in nociceptors
nor pain behavior. The first clue to solving this puzzle came with
the observation that protons can potently inhibit voltage-gated
sodium channel (NaV) subunits.
51 Voltage-gated sodium chan-
nels are necessary for action potential initiation and propagation,
as demonstrated by the fact that pathological mutations in some
genes encoding NaV subunits cause CIP.
21,58 Recent work
suggests that loss of function mutations in the SCN9A gene
encoding NaV1.7 leads to structural changes in nociceptors,
which may be the primary reason for nonfunctional nocicep-
tors.75 The NaV1.7 subunit is important for action potential
initiation and setting threshold,75 and the naked mole-rat gene
encodes amino acid variations that whenmutated into the human
protein considerably enhance proton block of NaV1.7 channels at
certain pH values that excite nociceptors.33,114 We also showed
that the low pH is a much more potent inhibitor of mechanically
evoked nociceptor firing in nakedmole-rat nociceptors than in the
mouse. Thus, our model predicts that at least one major
mechanism by which naked mole-rats have evolved acid
insensitivity is through highly specific changes in residues that
enhance proton block of the NaV1.7 channel.
114
8. Algogen insensitivity: a family affair
The extraordinary sensory attributes of the naked mole-rat
recently led us to ask whether pain insensitivity is a commonly
occurring attribute among African underground-dwelling
rodents. The naked mole-rat belongs to the family Bathyergidae,
a very species-rich group of mole-rats that have spread
throughout most of Africa. We systematically tested algogen
sensitivity in 8 mole-rat species and one root-rat species from
east Africa (Tachyoryctes splendens).27 We used 3 algogen
stimuli: capsaicin, acid (pH 3.5 HCl), and allyl isothiocyanate
(AITC); the latter molecule is the active pungent ingredient of
mustard oil and wasabi and is a highly electrophilic molecule that
is a specific agonist of TRPA1 ion channels.2,36,48,117 So far, not
just mammals find AITC and related TRPA1 ligands noxious, but
also flies, planaria, reptiles, and birds avoid this sub-
stance.1,50,88,105 We also showed that naked mole-rats display
robust nocifensive behavior after hind paw injection of AITC.27
Thus, naked mole-rats can display the same nocifensive
behaviors as all other rodents so far tested.
We discovered that one additional mole-rat species was
completely insensitive to capsaicin (the Natal mole-rat Crytomys
hottentotus natalensis) and 2 additional species were insensitive
to acid (Cape mole-rat [Georychus capensis] and East African
root-rat).27 The mechanisms that might underlie the loss of acid-
and capsaicin-induced pain in African rodents are discussed
below. Probably, most surprisingly, we also identified the first
case of complete insensitivity to the pungent chemical AITC in the
Highveld mole-rat. The Highveld mole-rat is a social Africanmole-
rat that belongs to theCrytomys genus and like other members of
the genus tested (Common mole-rat, Mahali mole-rat, and Natal
mole-rat), all these animals were found to harbor variants in the
TRPA1 channel that renders the channel much less sensitive to
the AITC ligand.27 However, the Highveld mole-rat was even
impervious to 100% AITC and normally displays no licking or
lifting behavior in the first phase of the formalin test.27 The
Highveld mole-rat was also unique among rodents tested so far
that it displayed no second phase sensitivity in the formalin test. It
is interesting to note in this context that a gain-of-function
mutation in the human trpa1 gene is associated with sporadic
pain in a large Columbian family.55 We conducted large-scale
transcriptome assemblies from sensory tissues collected from
the species tested and quantified changes in gene expression
across the phylogenetic tree (Fig. 3). This analysis revealed
a single upregulated transcript for Nalcn in the Highveld mole-rat
that encodes a nonselective leak channel. This voltage-
insensitive leak channel (NALCN) has been implicated in carrying
a background leak current in neurons.18,72 We speculated that in
Highveld sensory neurons, the hvNALCN protein is overex-
pressed to shunt excitability of nociceptors that detect AITC.
Evidence for this idea was provided by pretreating Highveldmole-
rats with an antagonist of the NALCN channel with the hope that
this would rescue AITC behavioral sensitivity. We used verapamil,
which has been shown to block NALCN channels,72 and
remarkably, after systemic treatment, the Highveld mole-rat
became transiently sensitive to both AITC and the effects of
formalin.27 Our data indicate that the Highveld mole-rat has
evolved an unusual and effective molecular strategy to become
impervious to pain and in principle, such a strategy could be
harnessed to develop new analgesics. We also gathered
evidence that the Highveld mole-rat lost sensitivity to TRPA1
ligands because it has adapted to sharing its nest with the Natal
droptail ant, the venom of which is a potent algogen.27
By testing a large number of African mole-rat species for acid
sensitivity, we discovered 2 new instances of acid insensitivity, in
the Cape mole-rat (G. capensis) and the East African root rat (T.
splendens). The Cape mole-rat and East African root rat are
subterranean rodents but are both solitary animals, thus they may
not be exposed to the same level of hypercapnic environment
probably experienced by the highly social naked mole-rat.
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Nevertheless, both the East African root rat and the Cape mole-rat
have acquired variants in the domain IV of the NaV1.7 channel that
convert a normally predominantly positively charged trio of amino
acids (KKV, charged 1/1/0 in mouse and human, single letter
amino acid abbreviations) into predominantly negatively charged
residues (EKD or EKE, both 2/1/2 in all subterranean African
mole-rats).24,27,29 It should be noted that EKE variant has been
shown experimentally to increase the proton block of the NaV1.7
channel. Interestingly, large-scale sequence analysis of the NaV1.7
channel across the animal kingdom revealed multiple instances of
convergent evolution in the same residues of the NaV1.7 channel
so that, for example, many hibernating species displayed the
naked mole-rat-like EKD variant, but closely related, nonhibernat-
ing species exhibited variants resembling the mouse or human
sequence.70 These data provide powerful evidence that the proton
sensitivity of the NaV1.7 channel is strongly associated with
situations of metabolic stress that could produce tissue acidosis
(hibernation is associated with metabolic stress). In our recent
study, we found that the acid-insensitive Cape mole-rat was the
only species that has the identical amino acid motif in domain IV of
the NaV1.7 channel as the naked mole-rat (EKE and not the more
common EKD sequence). This is only the second recorded
instance of such amotif, which is so far the onlymotif that has been
shown experimentally to increase the proton block of the
channel.27,70 Indeed, detailed analysis also revealed that a func-
tionally equivalent part of the NaV1.7 channel in domain III has
amino acid variants that are unique to the acid-insensitive African
mole-rats of the family Bathyergidae.27 The functional importance
of such variants, however, remains to be tested. At least in the case
of the naked mole-rat, it seems reasonable to assume that
exposure to high levels of carbon dioxide as consequence of living
in crowded colonies underground could be one factor driving acid
insensitivity. Naked mole-rats show an extraordinary resistance to
hypercapnia, which does not produce lung edema in this
species.92 We have also shown that naked mole-rats switch to
glycolytic metabolism that produces lactic acid when exposed to
extreme hypoxia.92 It thus seems feasible that acid insensitivity
evolved as a protectivemechanism to limit pain undermetabolically
stressful situations. Indeed, in the brain, naked mole-rats seem to
have smaller acid-induced currents and decreased acid-induced
cell death, suggesting a further protective mechanism.39 It was
recently reported that carbon dioxide levels are elevated in naked
mole-rat burrows,37 but that the level reached is less than that
generally associated with hypercapnia-induced changes in respi-
ration rate. However, the levels of carbon dioxide reached in
sleeping chambers where themajority of the colony sleep together
remain to bemeasured.We routinely observe that nakedmole-rats
assemble in piles of sleeping animals to sleep communally every
day multiple times, and it is very likely that animals sleeping at the
bottom of such piles will be exposed to very low oxygen and high
carbon dioxide.
Because the 3 acid-insensitive species observed here seem to
occupy different types of habitats, it was all the more surprising
that we could also detect multiple common genes that were
regulated in the same direction in the DRG of all 3 species. We
could show that all 3 species showed reduced levels of
transcripts encoding ion channels whose activity would be
enhanced by protons.27 Examples of such genes included
TWIK1 and ASIC3.15,108 However, we also discovered multiple
new genes involved in metabolic processes that may also help all
3 species cope with acidosis.
9. Why did selective pain insensitivities evolve?
It is hard to prove that loss of physiological trait in the course of
evolution, examples described here being sensitivity to acid,
Figure 3. Algogen insensitivities in African rodents. Phylogenetic tree of the studied rodent species, as calculated on the basis of transcriptomic data. Divergence
times were calculated on the basis of published and de novo assembled transcriptomes. An “X” indicates an insensitivity to the algogen. Mya, million years ago.
(Photo credits [top to bottom]: Karlien Debus, Gary Lewin, Jane Reznick) Illustration courtesy of Science.
September 2020·Volume 161·Number 9·Supplement 1 www.painjournalonline.com S43
capsaicin, or AITC, confer a selective advantage to the species in
question. In some cases, we can speculate about the benefits
that the loss of algogen sensitivity might bring the species, eg,
acid insensitivity in the naked mole-rat may help this species deal
with tissue acidosis associated with hypercapnia associated with
crowded underground living.92 Nevertheless, it is also possible
that some pain-insensitivity traits may have evolved for reasons
that are not primarily associated with pain per se. For example,
the specific loss of C-fiber nociceptors that was observed only in
the most social mole-rat species, the naked mole-rat, may be an
adaptation to a need for energetic efficiency rather than an
adaptation to it sensory world. The naked mole-rat occupies
a very food resource-poor niche, which puts energy efficiency at
a premium. Thus, it has been proposed that other adaptive traits
in this species, such as lack of fur and lack of thermogenesis, are
tradeoffs made to reduce energy expenditure where it is not
strictly required.5,9,43 Similarly, loss of some, but not all C-fibers,
that consume energy may also be a trade-off that benefits the
general fitness of the species.
In conclusion, studies on African mole-rats have so far
revealed novel molecular strategies to ameliorate pain. Strik-
ingly, the molecular changes used by mole-rats to reduce pain
have turned out to be remarkably overlapping with the causes of
human CIP. Of the 6main genes associated with CIP in humans,
2 (TrkA andNaV1.7) are directly associatedwith pain insensitivity
in naked mole-rats. Non-model rodents represent a highly
valuable resource to discover how evolution can produce novel
solutions that will in the end inform us how to best develop
therapeutic approaches for a variety of human illnesses as well
as pain.
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[41] JancsÓ G, Kiraly E, JancsÓ-Gábor A. Pharmacologically induced
selective degeneration of chemosensitive primary sensory neurones.
Nature 1977;270:741–3.
[42] Jarvis JU. Eusociality in amammal: cooperative breeding in nakedmole-
rat colonies. Science 1981;212:571–3.
[43] Jarvis JUM, O’Riain MJ, Bennett NC, Sherman PW. Mammalian
eusociality: a family affair. Trends Ecol Evol 1994;9:47–51.
[44] Jenq CB, Coggeshall RE. Numbers of regenerating axons in parent and
tributary peripheral nerves in the rat. Brain Res 1985;326:27–40.
[45] Jenq CB, Coggeshall RE. Regeneration of axons in tributary nerves.
Brain Res 1984;310:107–21.
[46] Jenq CB, Hulsebosch CE, Coggeshall RE, Perez-Polo JR. The effects of
nerve growth factor and its antibodies on axonal numbers in the medial
gastrocnemius nerve of the rat. Brain Res 1984;299:9–14.
[47] Jimenez-Andrade JM,Ghilardi JR, Castañeda-Corral G, KuskowskiMA,
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